Loading…

MiR-125b downregulates macrophage scavenger receptor type B1 and reverse cholesterol transport

To determine whether miR-125b regulates cholesterol efflux in vivo and in vitro through the regulation of scavenger receptor type B1 (SR-B1). We demonstrated that miR-125b is up-regulated in the human aortas of patients with CAD and is located in macrophages and vascular smooth muscle cells (VSMCs)....

Full description

Saved in:
Bibliographic Details
Published in:Biomedicine & pharmacotherapy 2022-02, Vol.146, p.112596-112596, Article 112596
Main Authors: Hueso, Miguel, Griñán, Raquel, Mallen, Adrián, Navarro, Estanislao, Purqueras, Elvira, Gomá, Montse, Sbraga, Fabrizio, Blasco-Lucas, Arnau, Revilla, Giovanna, Santos, David, Canyelles, Marina, Julve, Josep, Escolà-Gil, Joan Carles, Rotllan, Noemi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To determine whether miR-125b regulates cholesterol efflux in vivo and in vitro through the regulation of scavenger receptor type B1 (SR-B1). We demonstrated that miR-125b is up-regulated in the human aortas of patients with CAD and is located in macrophages and vascular smooth muscle cells (VSMCs). We identified SCARB1 as a direct target of miR-125b by repressing the activity of the SCARB1 3′-untranslated region reporter construct. Moreover, the overexpression of miR-125b in both human and mouse macrophages as well as VSMCs was found to downregulated the expression of the SCARB1 and the SR-B1 protein levels, thereby impairing α-HDL-mediated macrophage cholesterol efflux in vitro. The in vivo reverse cholesterol transport (RCT) rate from non-cholesterol-loaded macrophages transfected with miR-125b to feces was also found to be decreased when compared with that of control mimic-transfected macrophages. Together, these results provide evidence that miR-125b downregulates SCARB1 and SR-B1 in both human and mouse macrophages as well as VSMCs, thereby impairing macrophage cholesterol efflux in vitro and the whole macrophage-specific RCT pathway in vivo. [Display omitted] •miR-125b is expressed in the aortic macrophages and vascular smooth muscle cells of patients with coronary artery disease.•miR-125b downregulates macrophage and smooth muscle cell scavenger receptor SR-B1 and cholesterol efflux to α-HDL.•miR-125b impairs the entire macrophage-specific reverse cholesterol transport rate.
ISSN:0753-3322
1950-6007
DOI:10.1016/j.biopha.2021.112596